HRT patch vs. pill: which is safer for you?

HRT patch vs gel vs pill

This is not medical advice — it is general information based on what you searched for that may help.

General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.

Hormone therapy comes in more than one form, and the route you take it — not just the decision to take it — changes its safety profile. NICE guideline NG23 recommends this specifically as part of the conversation when you're deciding whether to take HRT at all.

The three main routes

Pill (oral): Taken by mouth daily. Convenient, but carries higher blood clot and stroke risk than the skin-based options below.
Patch (transdermal): Applied to the skin and changed every few days, releasing estrogen steadily. Not associated with increased VTE risk, and unlikely to increase stroke risk.
Gel (transdermal): Applied to the skin daily. Shares the same favorable clot and stroke profile as the patch, since both deliver estrogen through the skin rather than through the digestive system.

Why the route changes the risk

Oral estrogen passes through the liver before reaching the rest of the body, which affects clotting factors in a way that skin-based (transdermal) estrogen does not. That's the mechanism behind the risk difference NICE guidance describes: VTE risk is not increased with transdermal HRT, but is increased with oral HRT, and is greater with oral than transdermal. The same pattern holds for stroke risk, which is unlikely to increase with transdermal estrogen but increases with oral estrogen, rising further with higher doses and longer use. See our dedicated page on HRT and blood clot risk for the full breakdown.

So which one is right for you?

There's no single "best" route for everyone. Oral pills are simple and familiar, and work well for people without additional clot or stroke risk factors. Transdermal options (patch or gel) are often preferred for people with a higher BMI, a personal or family history of blood clots, or other cardiovascular risk factors, precisely because of the safety profile above. Beyond safety, personal factors matter too — skin sensitivity to patches, consistency with daily gel application, and how well a given route controls your specific symptoms.

Prepare for your appointment

If you're also curious how HRT compares with non-hormonal options overall, see our Does It Work? evidence directory. Bring these questions into our treatment conversation builder:

Given my personal risk factors, would a transdermal (patch or gel) route be preferable to a pill?
If transdermal is recommended, would a patch or a gel suit my routine and skin better?

Where are you right now?

Still tracking

Not sure if your symptoms fit? Start tracking your daily patterns.

Log and spot your patterns with the symptom checklist →

Ready to talk to a doctor

Have an upcoming appointment? Bring structured questions and your history.

Prepare your 10-minute doctor appointment questions →

Already on treatment

Evaluating your response or wondering what to adjust next?

Explore evidence-graded treatment and lifestyle options →

Questions people ask

Is a patch safer than a pill?

For blood clot and stroke risk specifically, NICE guidance indicates transdermal estrogen (patch or gel) is associated with lower risk than oral estrogen (pills). That doesn't automatically make a patch the right choice for everyone — your personal risk factors, preferences, and how well a given route controls your symptoms all matter too.

Gel or patch — which should I choose?

Both are transdermal (through-the-skin) routes and share the lower clot and stroke risk profile compared with pills. The choice between gel and patch usually comes down to personal preference, skin sensitivity, and how consistently you can apply either one daily (gel) or every few days (patch), which is worth discussing directly with your clinician.